{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:11:37Z","timestamp":1781071897576,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Yangzi River Pharmaceuticals Group"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ejphar.2020.173062","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T03:59:57Z","timestamp":1583985597000},"page":"173062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Dual \u03bc-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain"],"prefix":"10.1016","volume":"876","author":[{"given":"Xiao-Fang","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zaeem","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evhy","family":"Apryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173062_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.36076\/ppj.2013\/16\/27","article-title":"Efficacy of tapentadol ER for managing moderate to severe chronic pain","volume":"16","author":"Afilalo","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.ejphar.2020.173062_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.intimp.2017.01.005","article-title":"Role of central opioid on the antinociceptive effect of sulfated polysaccharide from the red seaweed Solieria filiformis in induced temporomandibular joint pain","volume":"44","author":"Araujo","year":"2017","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2020.173062_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pain.2010.10.004","article-title":"Mu-opioid and noradrenergic alpha(2)-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats","volume":"152","author":"Bee","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173062_bib4","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/jama.290.18.2476","article-title":"Cancer pain","volume":"290","author":"Bruera","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2020.173062_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/papr.12556","article-title":"Tapentadol for cancer pain management: a narrative review","volume":"17","author":"Carmona-Bayonas","year":"2017","journal-title":"Pain Pract. : the official journal of World Institute of Pain"},{"key":"10.1016\/j.ejphar.2020.173062_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3344\/kjp.2016.29.3.153","article-title":"Tapentadol: can it kill two birds with one stone without breaking windows?","volume":"29","author":"Chang","year":"2016","journal-title":"Kor. J. Pain"},{"key":"10.1016\/j.ejphar.2020.173062_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1389557516666160609065535","article-title":"alpha2 adrenoceptor: a target for neuropathic pain treatment","volume":"17","author":"Di Cesare Mannelli","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173062_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/bja\/53.1.59","article-title":"WY 16225 (dezocine), a new synthetic opiate agonist-antagonist and potent analgesic: comparison with morphine for relief of pain after lower abdominal surgery","volume":"53","author":"Downing","year":"1981","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2020.173062_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0304-3959(88)90042-5","article-title":"Synergy between the antinociceptive effects of intrathecal clonidine and systemic morphine in the rat","volume":"32","author":"Drasner","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173062_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ejp.530","article-title":"Spinal neuronal correlates of tapentadol analgesia in cancer pain: a back-translational approach","volume":"19","author":"Falk","year":"2015","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2020.173062_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1213\/00000539-197857050-00010","article-title":"Comparison of dezocine (WY 16, 225) and meperidine as postoperative analgesics","volume":"57","author":"Fragen","year":"1978","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2020.173062_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00000542-198412000-00015","article-title":"Ventilatory and analgesic effects of dezocine in humans","volume":"61","author":"Gal","year":"1984","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2020.173062_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2202-3-19","article-title":"Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors","volume":"3","author":"Gharagozlou","year":"2002","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejphar.2020.173062_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2210-3-1","article-title":"Activity of opioid ligands in cells expressing cloned mu opioid receptors","volume":"3","author":"Gharagozlou","year":"2003","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173062_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2210-6-3","article-title":"Pharmacological profiles of opioid ligands at kappa opioid receptors","volume":"6","author":"Gharagozlou","year":"2006","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173062_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.tvjl.2012.05.019","article-title":"Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs","volume":"194","author":"Giorgi","year":"2012","journal-title":"Vet. J."},{"key":"10.1016\/j.ejphar.2020.173062_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/104990910302000213","article-title":"A prospective study of the pathophysiology and clinical characteristics of pain in a palliative medicine population","volume":"20","author":"Gutgsell","year":"2003","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"10.1016\/j.ejphar.2020.173062_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neuroscience.2010.11.057","article-title":"A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception","volume":"175","author":"Hall","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173062_bib19","doi-asserted-by":"crossref","first-page":"Pl195","DOI":"10.1016\/S0024-3205(00)00457-4","article-title":"Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests","volume":"66","author":"Hao","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173062_bib20","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1517\/13543784.2012.731393","article-title":"Noradrenergic reuptake inhibition in the treatment of pain","volume":"21","author":"Hartrick","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2020.173062_bib21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00726-012-1390-z","article-title":"Contributions of spinal D-amino acid oxidase to bone cancer pain","volume":"43","author":"Huang","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2020.173062_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-016-0696-2","article-title":"Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models","volume":"13","author":"Huang","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2020.173062_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2017.02.005","article-title":"Cynandione A attenuates neuropathic pain through p38beta MAPK-mediated spinal microglial expression of beta-endorphin","volume":"62","author":"Huang","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2020.173062_bib24","article-title":"Comparative efficacy of therapeutics for chronic cancer pain: a Bayesian network meta-analysis","author":"Huang","year":"2019","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2020.173062_bib25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7547\/87507315-82-10-520","article-title":"Opioid receptor affinity for agonist-antagonist analgesics","volume":"82","author":"Jacobs","year":"1992","journal-title":"J. Am. Podiatr. Med. Assoc."},{"key":"10.1016\/j.ejphar.2020.173062_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(82)90397-1","article-title":"Role of 5-HT and NA in spinal dopaminergic analgesia","volume":"86","author":"Jensen","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173062_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3344\/kjp.2014.27.1.23","article-title":"Spinal noradrenergic modulation and the role of the alpha-2 receptor in the antinociceptive effect of intrathecal nefopam in the formalin test","volume":"27","author":"Jeong","year":"2014","journal-title":"Kor. J. Pain"},{"key":"10.1016\/j.ejphar.2020.173062_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0929-6646(10)60075-7","article-title":"Norepinephrine can act via alpha(2)-adrenoceptors to reduce the hyper-excitability of spinal dorsal horn neurons following chronic nerve injury","volume":"109","author":"Jiang","year":"2010","journal-title":"J. Formos. Med. Assoc. = Taiwan yi zhi"},{"key":"10.1016\/j.ejphar.2020.173062_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neulet.2013.03.026","article-title":"Role of spinal opioid receptor on the antiallodynic effect of intrathecal nociceptin in neuropathic rat","volume":"542","author":"Ju","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2020.173062_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122626","article-title":"Duloxetine protects against oxaliplatin-induced neuropathic pain and spinal neuron hyperexcitability in rodents","volume":"18","author":"Kim","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2020.173062_bib31","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2147\/JPR.S191543","article-title":"Tapentadol in the management of cancer pain: current evidence and future perspectives","volume":"12","author":"Kress","year":"2019","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2020.173062_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000492394","article-title":"Antiallodynic effects of intrathecal areca nut for spinal nerve-ligated and chemotherapy-induced neuropathic pain in rats","volume":"102","author":"Lee","year":"2018","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2020.173062_bib33","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1213\/ANE.0000000000001212","article-title":"Electroacupuncture enhances the antiallodynic and antihyperalgesic effects of milnacipran in neuropathic rats","volume":"122","author":"Li","year":"2016","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2020.173062_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jpain.2015.12.015","article-title":"Aconitum-derived bulleyaconitine A exhibits antihypersensitivity through direct stimulating dynorphin A expression in spinal microglia","volume":"17","author":"Li","year":"2016","journal-title":"J. Pain : Off. J. Am. Pain Soc."},{"key":"10.1016\/j.ejphar.2020.173062_bib35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s13346-018-0524-6","article-title":"Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics","volume":"8","author":"Li","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejphar.2020.173062_bib36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/ALN.0000000000000076","article-title":"Novel molecular targets of dezocine and their clinical implications","volume":"120","author":"Liu","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2020.173062_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0022-3565(25)30283-1","article-title":"Animal pharmacology of Wy-16,225, a new analgesic agent","volume":"194","author":"Malis","year":"1975","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173062_bib38","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/03007995.2017.1379981","article-title":"The role of tapentadol as a strong opioid in cancer pain management: a systematic and critical review","volume":"33","author":"Mercadante","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejphar.2020.173062_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2018.08.041","article-title":"Spinal mechanisms of pudendal nerve stimulation-induced inhibition of bladder hypersensitivity in rats","volume":"686","author":"Ness","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2020.173062_bib40","first-page":"226","article-title":"Dezocine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"38","author":"O'Brien","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2020.173062_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112483","article-title":"Analgesic mechanisms of antidepressants for neuropathic pain","volume":"18","author":"Obata","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2020.173062_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2015\/902914","article-title":"Spinal antinociceptive action of amiloride and its interaction with tizanidine in the rat formalin test","volume":"20","author":"Ouyang","year":"2015","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.ejphar.2020.173062_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/j.1552-4604.1986.tb03523.x","article-title":"Intravenous dezocine for postoperative pain: a double-blind, placebo-controlled comparison with morphine","volume":"26","author":"Pandit","year":"1986","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173062_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3959(92)90201-L","article-title":"Antinociceptive and motor effects of intrathecal morphine combined with intrathecal clonidine, noradrenaline, carbachol or midazolam in rats","volume":"49","author":"Plummer","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173062_bib45","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/JPR.S190154","article-title":"Tapentadol: an overview of the safety profile","volume":"12","author":"Polati","year":"2019","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2020.173062_bib46","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejphar.2020.173062_bib47","first-page":"353","article-title":"The relationship of analgesia effect of Dezocine and kappa opioid receptors","volume":"32","author":"Qiao","year":"2012","journal-title":"J. Nant. Univ. (medicaI Sciences)"},{"key":"10.1016\/j.ejphar.2020.173062_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/clpt.1984.45","article-title":"Ceiling respiratory depression by dezocine","volume":"35","author":"Romagnoli","year":"1984","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173062_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4103\/1658-354X.115319","article-title":"Tapentadol hydrochloride: a novel analgesic","volume":"7","author":"Singh","year":"2013","journal-title":"Saudi J. Anaesth."},{"key":"10.1016\/j.ejphar.2020.173062_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-9556(25)06040-4","article-title":"The metabolic disposition of dezocine in rhesus monkeys and female rats given 14C-dezocine intragastrically","volume":"9","author":"Sisenwine","year":"1981","journal-title":"Drug Metab. Dispos.: The Biological Fate of Chemicals"},{"key":"10.1016\/j.ejphar.2020.173062_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(79)90335-2","article-title":"Antinociceptive activity of clonidine and its potentiation of morphine analgesia","volume":"58","author":"Spaulding","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173062_bib52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00213-007-0898-5","article-title":"Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats","volume":"195","author":"Steinmiller","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173062_bib53","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00213-018-4948-y","article-title":"Lappaconitine, a C18-diterpenoid alkaloid, exhibits antihypersensitivity in chronic pain through stimulation of spinal dynorphin A expression","volume":"235","author":"Sun","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173062_bib54","series-title":"Cancer Pain (PDQ(R)): Health Professional Version, PDQ Cancer Information Summaries","article-title":"Palliative care editorial, B","author":"Supportive","year":"2002"},{"key":"10.1016\/j.ejphar.2020.173062_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173062_bib56","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF03190478","article-title":"Absorption, metabolism, and excretion of 14C-labeled tapentadol HCl in healthy male subjects","volume":"32","author":"Terlinden","year":"2007","journal-title":"Eur. J. Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2020.173062_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.107.126052","article-title":"(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties","volume":"323","author":"Tzschentke","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173062_bib58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40263-014-0151-9","article-title":"The mu-opioid receptor agonist\/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol","volume":"28","author":"Tzschentke","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2020.173062_bib59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1358\/dot.2009.45.7.1395291","article-title":"Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule","volume":"45","author":"Tzschentke","year":"2009","journal-title":"Drugs Today"},{"key":"10.1016\/j.ejphar.2020.173062_bib60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JPR.S14842","article-title":"Tapentadol extended-release for treatment of chronic pain: a review","volume":"4","author":"Vadivelu","year":"2011","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2020.173062_bib61","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170243","article-title":"Comparison of the efficacy and safety between dezocine injection and morphine injection for persistence of pain in Chinese cancer patients: a meta-analysis","volume":"37","author":"Wang","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2020.173062_bib62","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1038\/s41598-018-32568-y","article-title":"Pharmacological characterization of dezocine, a potent analgesic acting as a kappa partial agonist and mu partial agonist","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173062_bib63","doi-asserted-by":"crossref","first-page":"43137","DOI":"10.1038\/srep43137","article-title":"Dezocine exhibits antihypersensitivity activities in neuropathy through spinal mu-opioid receptor activation and norepinephrine reuptake inhibition","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173062_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-3565(25)38086-9","article-title":"Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase","volume":"265","author":"Wang","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173062_bib65","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1213\/ANE.0000000000003365","article-title":"Dezocine alleviates morphine-induced dependence in rats","volume":"128","author":"Wu","year":"2019","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2020.173062_bib66","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbi.2018.06.015","article-title":"Spinal interleukin-10 produces antinociception in neuropathy through microglial beta-endorphin expression, separated from antineuroinflammation","volume":"73","author":"Wu","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2020.173062_bib67","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.pain.2013.07.027","article-title":"Gelsemine, a principal alkaloid from Gelsemium sempervirens Ait., exhibits potent and specific antinociception in chronic pain by acting at spinal alpha3 glycine receptors","volume":"154","author":"Zhang","year":"2013","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920301540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920301540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:36:13Z","timestamp":1757975773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920301540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":67,"alternative-id":["S0014299920301540"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173062","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual \u03bc-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173062"}}